NORDIC BIOTECH K/S: Financial statements 2019
CVR: 26290724
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 12,997,000 compared with DKK -464,676,000 the year before. Equity in the 2019 report amounted to DKK 86,469,000. The solvency ratio was 99.8%.
- Profit/Loss
- DKK 12,997,000
- Equity
- DKK 86,469,000
- Total Assets
- DKK 86,604,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | 13M | 86.5M | 0 |
| 2018 | - | - | -464.7M | 73.5M | - |
| 2017 | - | - | 149.6M | 538.1M | - |
| 2016 | - | - | -1.1B | 2.3B | - |
| 2015 | - | - | 317.4M | 3.4B | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
NORDIC BIOTECH K/S has published its annual report for 2018. The net result was DKK -464,676,000.
About NORDIC BIOTECH K/S
NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.
